Evolent Health, Inc.

DB:9EH Stock Report

Market Cap: €1.2b

Evolent Health Management

Management criteria checks 2/4

Evolent Health's CEO is Seth Blackley, appointed in Jan 2011, has a tenure of 13.92 years. total yearly compensation is $8.93M, comprised of 8.8% salary and 91.2% bonuses, including company stock and options. directly owns 0.27% of the company’s shares, worth €3.32M. The average tenure of the management team and the board of directors is 3.8 years and 4.5 years respectively.

Key information

Seth Blackley

Chief executive officer

US$8.9m

Total compensation

CEO salary percentage8.8%
CEO tenure13.9yrs
CEO ownership0.3%
Management average tenure3.8yrs
Board average tenure4.5yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Seth Blackley's remuneration changed compared to Evolent Health's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$104m

Jun 30 2024n/an/a

-US$106m

Mar 31 2024n/an/a

-US$141m

Dec 31 2023US$9mUS$783k

-US$142m

Sep 30 2023n/an/a

-US$112m

Jun 30 2023n/an/a

-US$77m

Mar 31 2023n/an/a

-US$40m

Dec 31 2022US$8mUS$683k

-US$19m

Sep 30 2022n/an/a

-US$4m

Jun 30 2022n/an/a

-US$19m

Mar 31 2022n/an/a

-US$24m

Dec 31 2021US$7mUS$600k

-US$30m

Sep 30 2021n/an/a

-US$45m

Jun 30 2021n/an/a

-US$68m

Mar 31 2021n/an/a

-US$261m

Dec 31 2020US$4mUS$438k

-US$328m

Sep 30 2020n/an/a

-US$515m

Jun 30 2020n/an/a

-US$504m

Mar 31 2020n/an/a

-US$334m

Dec 31 2019US$3mUS$400k

-US$304m

Sep 30 2019n/an/a

-US$121m

Jun 30 2019n/an/a

-US$107m

Mar 31 2019n/an/a

-US$86m

Dec 31 2018US$2mUS$400k

-US$53m

Sep 30 2018n/an/a

-US$49m

Jun 30 2018n/an/a

-US$49m

Mar 31 2018n/an/a

-US$56m

Dec 31 2017US$2mUS$400k

-US$61m

Compensation vs Market: Seth's total compensation ($USD8.93M) is above average for companies of similar size in the German market ($USD1.52M).

Compensation vs Earnings: Seth's compensation has increased whilst the company is unprofitable.

CEO

Seth Blackley (45 yo)

13.9yrs

Tenure

US$8,931,188

Compensation

Mr. Seth Barrie Blackley is Director of Iodine Software, LLC. He serves as Chief Executive Officer at Evolent Health, Inc. since October 1, 2020. He serves as President of True Health Indiana, Inc. (True H...

Leadership Team

NamePositionTenureCompensationOwnership
Seth Blackley
Co-Founder13.9yrsUS$8.93m0.27%
€ 3.3m
Dan McCarthy
President2.3yrsUS$5.76m0.16%
€ 2.0m
John Johnson
Chief Financial Officer5.4yrsUS$3.53m0.15%
€ 1.8m
Emily Rafferty
Chief Operating Officer1.4yrsUS$2.69m0.055%
€ 676.8k
Jonathan Weinberg
Chief Legal Officer10.9yrsUS$2.01m0.11%
€ 1.3m
Aammaad Shams
Chief Accounting Officer4.5yrsUS$634.88k0.020%
€ 243.6k
Robert Cruz
Chief Technology Officerno datano datano data
Jessica White
Chief Information Officerless than a yearno datano data
Seth Frank
Vice President of Investor Relations3yrsno datano data
Katie Cook
Chief People Officerless than a yearno datano data
John Tam
Chief Strategy Officer12.9yrsno datano data
Scott Pritchard
President of Performance Suiteno datano datano data

3.8yrs

Average Tenure

40.5yo

Average Age

Experienced Management: 9EH's management team is considered experienced (3.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Seth Blackley
Co-Founder6.7yrsUS$8.93m0.27%
€ 3.3m
Peter Grua
Independent Director4.9yrsUS$260.25k0.036%
€ 447.4k
Richard Jelinek
Independent Director1.5yrsUS$245.50k0.0059%
€ 72.1k
Russell Glass
Independent Directorless than a yearno data0.0053%
€ 64.6k
Cheryl Scott
Independent Chairperson of the Board & Lead Independent Director9.1yrsUS$347.75k0.038%
€ 467.5k
Diane Holder
Independent Director13.3yrsUS$265.25k0.048%
€ 588.0k
Mary Duffy
Independent Director7.3yrsUS$255.25k0.035%
€ 430.1k
Kim Keck
Independent Director3.9yrsUS$265.25k0.018%
€ 227.0k
Craig Barbarosh
Independent Director4yrsUS$257.50k0.019%
€ 237.5k
Toyin Ajayi
Independent Director1.4yrsUS$195.83k0%
€ 0

4.5yrs

Average Tenure

59yo

Average Age

Experienced Board: 9EH's board of directors are considered experienced (4.5 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/29 15:55
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Evolent Health, Inc. is covered by 23 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Matthew GillmorBaird
David LarsenBTIG
Richard CloseCanaccord Genuity